Bill Sponsor
House Bill 913
116th Congress(2019-2020)
CLINICAL TREATMENT Act
Introduced
Introduced
Introduced in House on Jan 30, 2019
Overview
Text
Introduced
Jan 30, 2019
Latest Action
Jan 30, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
913
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
New Mexico
Republican
Alaska
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
District of Columbia
Democrat
Illinois
Democrat
Maryland
Democrat
Maryland
Democrat
Massachusetts
Democrat
Massachusetts
Democrat
Minnesota
Democrat
Minnesota
Republican
Minnesota
Republican
Nebraska
Republican
New York
Democrat
New York
Democrat
New York
Democrat
North Carolina
Democrat
North Carolina
Republican
Oklahoma
Republican
Pennsylvania
Democrat
Pennsylvania
Democrat
Pennsylvania
Democrat
Pennsylvania
Democrat
Pennsylvania
Democrat
Virginia
Democrat
Washington
Republican
West Virginia
Democrat
Wisconsin
Democrat
Wisconsin
Democrat
Wisconsin
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Covering Life-saving Investigations Needed in Cancer and Other Life-threatening Conditions through Timely use of Resources for Easy and Affordable Treatment from Medicaid for Enrollees in Need Today Act or the CLINICAL TREATMENT Act

This bill requires state Medicaid programs to cover routine patient costs for items and services that are provided in connection with a qualifying clinical trial regarding cancer or other life-threatening conditions.

The bill defines "routine patient costs" to include items and services that would otherwise be covered under Medicaid absent the patient's participation in the clinical trial; the term includes items and services relating to trial complications, but excludes those items and services that are the subject of the trial or that are provided solely in relation to data analysis.

Additionally, a "qualifying clinical trial" means, among other things, a clinical trial that is approved or funded by specified entities (e.g., the National Institutes of Health) or is an authorized new drug trial.

Text (1)
January 30, 2019
Actions (2)
01/30/2019
Referred to the House Committee on Energy and Commerce.
01/30/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 3:17:46 PM